• Topics
  • Soaring Weight Loss Drugs Demands Push Wegovy Maker Shares Higher

Soaring Weight Loss Drugs Demands Push Wegovy Maker Shares Higher

The dazzling success of weight-loss drugs in the United States is leading Novo-Nordisk shares higher.

Related News

Can the Wealth Creation Myths of Novo Nordisk & Eli Lilly Continue After Outperforming Analyst Target Prices?

Column · Sep 12, 2023 06:21

Weight-Loss Drug Craze: The Potential Winners and Losers

Column · Sep 6, 2023 06:21

Are Weight Loss Stocks Expected to Take Over from AI as the New US Stock Hotspots in 2023?

Column · Aug 18, 2023 07:04

Pfizer Stock Is Plunging Today - What's Going On

Benzinga · Jun 26, 2023 09:47

NVO +2.57% PFE -0.64%

Pill for Obesity Has Wall Street Salivating

Dow Jones · Jun 26, 2023 09:20

NVO +2.57% LLY +3.25%

Pfizer Sells Off After Discontinuing Weight Loss Drug

Dow Jones · Jun 26, 2023 09:11

NVO +2.57% LLY +3.25%

Pfizer Shares Jump 4% After Diabetes Drug Shows Weight-loss Results

Dow Jones · May 22, 2023 13:37

NVO +2.57% PFE -0.64%

13F Tracking: Changes in 2022 Q4 Institutional Positions

Column · Feb 15, 2023 06:50

New obesity drugs from Lilly and Novo Nordisk generate excitement

Dow Jones · Jun 8, 2022 21:58

NVO +2.57% LLY +3.25%